MSA
GILD icon

Marino Stram & Associates’s Gilead Sciences GILD Stock Holding History

Marino Stram & Associates’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-23
Closed -$1K – 266
2019
Q1 		$1K Sell
23
-8
-26% -$532 ﹤0.01% 584
2018
Q4 		$2K Hold
31
– – ﹤0.01% 476
2018
Q3 		$2K Hold
31
– – ﹤0.01% 402
2018
Q2 		$2K Sell
31
-31
-50% -$2.19K ﹤0.01% 403
2018
Q1 		$5K Hold
62
– – ﹤0.01% 376
2017
Q4 		$4K Buy
+62
New +$4.71K ﹤0.01% 400

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Marino Stram & Associates's GILD Position: Q2 2019 in Review

Marino Stram & Associates sold out of Gilead Sciences (GILD) in Q2 2019, closing a stake of 23 shares — an estimated $1K sold.

Marino Stram & Associates first reported a position in GILD in Q4 2017 and held it in 6 quarters. The position peaked at $5K in Q1 2018. 1,483 funds tracked by Wall St. Rank hold GILD as of Q2 2019.

  • Marino Stram & Associates reported no remaining Gilead Sciences position as of Q2 2019 after selling out during the quarter.
  • Marino Stram & Associates sold 23 Gilead Sciences shares in Q2 2019, an estimated $1K.
  • Marino Stram & Associates first reported a position in Gilead Sciences in Q4 2017 and held it in 6 quarters.
  • Marino Stram & Associates's Gilead Sciences position peaked at $5K in Q1 2018.
  • 1,483 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2019.

Based on Marino Stram & Associates's 13F filing for Q2 2019, filed 19 Jul 2019.